Stock Analysis

CYBERDYNE Third Quarter 2025 Earnings: JP¥0.37 loss per share (vs JP¥1.65 loss in 3Q 2024)

TSE:7779
Source: Shutterstock

CYBERDYNE (TSE:7779) Third Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥1.03b (down 8.0% from 3Q 2024).
  • Net loss: JP¥79.0m (loss narrowed by 77% from 3Q 2024).
  • JP¥0.37 loss per share (improved from JP¥1.65 loss in 3Q 2024).
earnings-and-revenue-growth
TSE:7779 Earnings and Revenue Growth February 17th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

CYBERDYNE Earnings Insights

Looking ahead, revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 6.9% growth forecast for the Medical Equipment industry in Japan.

Performance of the Japanese Medical Equipment industry.

The company's shares are up 11% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for CYBERDYNE that you should be aware of before investing here.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:7779

CYBERDYNE

Researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare in Japan, the United States, Europe, the Middle East, Africa, and the Asia Pacific countries.

High growth potential with adequate balance sheet.